Dyrenium is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Wellspring Pharmaceutical Corporation. The primary component is Triamterene.
| Product ID | 65197-002_96d12576-d968-41bc-ad64-fd3812e09f25 |
| NDC | 65197-002 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Dyrenium |
| Generic Name | Triamterene |
| Dosage Form | Capsule |
| Route of Administration | ORAL |
| Marketing Start Date | 1999-10-01 |
| Marketing End Date | 2019-12-31 |
| Marketing Category | NDA / NDA |
| Application Number | NDA013174 |
| Labeler Name | WellSpring Pharmaceutical Corporation |
| Substance Name | TRIAMTERENE |
| Active Ingredient Strength | 50 mg/1 |
| Pharm Classes | Decreased Renal K+ Excretion [PE],Increased Diuresis [PE],Potassium-sparing Diuretic [EPC] |
| NDC Exclude Flag | N |
| Marketing Start Date | 1999-10-01 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA013174 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 1999-10-01 |
| Marketing End Date | 2019-12-31 |
| Marketing Category | NDA |
| Application Number | NDA013174 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2012-10-11 |
| Marketing End Date | 2019-12-31 |
| Ingredient | Strength |
|---|---|
| TRIAMTERENE | 50 mg/1 |
| SPL SET ID: | 5012f997-9fb2-4c3d-99fd-4f7efd7c39af |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 59212-002 | Dyrenium | Triamterene |
| 59212-003 | Dyrenium | Triamterene |
| 65197-002 | Dyrenium | Triamterene |
| 65197-003 | Dyrenium | Triamterene |
| 68151-1494 | Dyrenium | Triamterene |
| 66993-831 | triamterene | Triamterene |
| 66993-832 | Triamterene | Triamterene |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() DYRENIUM 72193818 0785081 Live/Registered |
SMITH KLINE & FRENCH LABORATORIES 1964-05-19 |